iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Join SI Premium – FREE
iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($1.05), $0.12 better than the analyst estimate of ($1.17).
For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple suing OpenAI over alleged misappropriation of trade secrets
- iQSTEL restructures corporate entities in internal realignment
- SK Hynix CEO: memory chip shortage may persist beyond 2030, 2027 will be the worst year
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
